Delivery Order SPE2DB22D3301-SPE2DB25FX9FR

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,168.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,844 units of Cetirizine HCL 5 mg tablets, a generic antihistamine medication, with a completion date of January 7, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,048.75 firm fixed-price delivery order contract is for the supply of Cetirizine HCL 10 mg tablets. The contract is not designated as a set-aside and serves as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, with a ceiling value of $1,085.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565626839 CETIRIZINE HCL 10 MG TABLET 300S, a generic pharmaceutical product, with an ultimate completion date of August 30, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a Set-Aside. Amerisourcebergen holds several...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Cetirizine Hydrochloride 10 mg Tablets, packaged in 300-count bottles. The $2,490.44 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) vehicle between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the government to efficiently procure a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,686.91 firm fixed-price delivery order covers the supply of 4,566,693,120 units of the drug Cetirizine HCL 10 mg tablets. The award has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
The federal contract award is for the delivery of 4,567,154 units of Cetirizine HCL 5 mg tablets in 100-count packages. The contract, valued at $1,121.39, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a firm fixed-price pricing type and a completion date of February 5, 2025. There is no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,314.71 Firm Fixed Price Delivery Order covers the supply of 4,566,731,869 units of Cetirizine HCL 10 mg tablets in 100-count bottles, with a completion date of December 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $1,031.04, is for the delivery of cetirizine 10mg tablets in 500-count bottles. This is a firm fixed-price delivery order contract that has a completion date of June 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The $1,158.96 firm fixed-price delivery order is for the supply of Cetirizine Hydrochloride 10 mg tablets, a generic antihistamine medication. The contract has an ultimate completion date of February 21, 2024 and was awarded on February 20, 2024. There was no set-aside designation for this contract. Amerisourcebergen...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,907.12 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,881,452 units of cetirizine HCL 10 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX9FR
    Delivery Order

This federal contract award, valued at $1,300.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567090405 - CETIRIZINE HCL 10 MG TABLET 100S, a pharmaceutical product, with a completion date of January 30, 2025.

The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations, indicating open competition.

Generated 4/30/25, 9:42 AM